Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018- 205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
January 19,2023 From:https://finance.yahoo.com/news/vial-announces-enrollment-first-patient-220000750.html
